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Abstract 
Objectives: Reliable predictors of response to lithium are still lacking in bipolar disorders (BD). 
However, childhood trauma has been hypothesized to be associated with poor response to lithium.  
Methods: We included 148 patients with BD, euthymic when retrospectively and clinically assessed 
for response to lithium and childhood trauma using reliable scales.  
Results: According to the “Alda scale”, the sample consisted in 20.3% of excellent responders, 49.3% 
of partial responders and 30.4% of non-responders to lithium. A higher level of physical abuse 
significantly correlated with a lower level of response to lithium (p=0.009). As compared to patients 
not exposed to any abuse, patients with at least two trauma abuses (emotional, physical or sexual) 
were more at risk of belonging to the non-responders group (OR=4.91 95CI(1.01-27.02)). Among 
investigated clinical variables, lifetime presence of mixed episodes and alcohol misuse were 
associated to non-response to lithium. Multivariate analyses demonstrated that physical abuse and 
mixed episodes were independently associated with poor response to lithium (p=0.005 and p=0.013 
respectively).  
Conclusions: Childhood physical abuse might be involved in a poor future response to lithium 
prophylaxis, this effect being independent of the association between clinical expression of BD and 
poor response to lithium.  
 
 
Key words 
Bipolar disorder, lithium response, childhood trauma, physical abuse, mixed episodes, alcohol 
misuse 
 
Significant outcomes 
A higher level of physical abuse significantly correlated with a lower level of response to lithium. 
Patients with high exposure to trauma had a 4-fold increased risk of being non-responders to 
lithium. 
History of physical abuse and mixed episodes were independently associated with poor response to 
lithium.  
Limitations 
The sample size was relatively small. 
All assessments were made retrospectively. 
The study was cross-sectional and causality cannot be definitively determined.   
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Introduction 
 
Predicting response to lithium in Bipolar Disorders (BD) is challenging but crucial for moving towards 
more personalized medicine (1). This is because, not all patients receiving lithium carbonate for at 
least two cumulative years of treatment will display improvement in the frequency and/or severity 
of mood recurrences. For example, by reviewing charts of 120 patients with BD and using the 
Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder 
(also referred as the “Alda scale”) (2), Garnham and colleagues identified that the highest rate of 
complete response to lithium is observed for only approximately 30% of patients (3). Within the 
ConLiGen consortium (The International Consortium on Lithium Genetics), Manchia and colleagues 
have performed a study including 1,308 patients with BD from 29 sites and assessing response to 
lithium with the “Alda scale” (4). Mixture modelling of score distribution indicated three 
subpopulations (full responders, partial responders, non-responders) with around one-third of 
patients belonging to each groups. 
 
Several variables related to BD clinical presentation have been extensively studied to identify those 
that would predict response to lithium when the treatment is first prescribed, although with 
disappointing results and a lack of consensus about robust predictors (5). In particular, Kleindienst et 
al. in 2005 used a meta-analytic approach to identify those predictive variables (6) and investigated 
forty-two potential clinical predictors. An episodic pattern sequence of mania-depression-interval 
and a late age at onset of BD predicted good response to lithium. A high number of previous 
hospitalizations, an episodic pattern sequence of depression-mania-interval, and continuous cycling 
predicted poor response to lithium. All the associations with these variables exhibited significant but 
small effect sizes, the larger effect size being observed for high number of hospitalizations.  Another 
variable that is likely to predict good response to lithium is a history of good response in the 
patient’s affected relatives, response to lithium being thus suggested as a familial trait (7, 8). 
Although it requires replications, patients who started lithium early during the course of the disorder 
were expected to have significantly increased rates of response to lithium as compared to patients 
starting lithium later (9). Some medical conditions have also been suggested to predict or to be 
associated with poor response to lithium (10). This was particularly the case for obesity, insulin 
resistance or type 2 diabetes (11-13).  
 
Recently, studies have investigated the history of childhood traumatic events as a predictor of non-
response to psychotropic drugs in psychiatry. Several studies have suggested an association between 
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early life adversity or childhood trauma and lower response or resistance to medication in 
depression in adults or adolescents (14-18). This issue has also been addressed in schizophrenia 
spectrum disorders with less convincing results (19). Only two studies have investigated such a 
hypothesis specifically in BD. Cakir et al. 2015 have used a sample of 135 patients with BD type I 
assessed for childhood trauma. Response to long-term treatment was determined from the records 
of life charts of the prospective follow-up project (20). They found no significant differences 
between good and poor response groups to long-term lithium treatment on childhood trauma 
scores. A study of 38 preschool-onset BD young patients who insufficiently responded to lithium 
monotherapy suggested that a history of sexual or physical abuse was a significant predictor of an 
inadequate response to lithium monotherapy, then requiring augmentation with risperidone (21).  
 
Interestingly, childhood trauma has been associated with several clinical variables that are likely to 
be associated with poor lithium response such as early onset, mixed features, rapid cycling, and 
substance misuse (22-26). Moreover, childhood trauma has been associated with numerous medical 
conditions such as obesity (27, 28), cardiovascular diseases, asthma, gastric ulcers, migraine, arthritis 
(29), metabolic risk markers (30) or diabetes (31). Some of these somatic conditions were in turn 
associated with poor response to lithium as mentioned above. This means that patients with BD and 
childhood trauma might experience not only a more severe course of BD but also a greater burden 
due to associated medical conditions. Whether childhood trauma predisposes to poor response to 
lithium directly or through the occurrence of some clinical psychiatric manifestations or some 
associated medical conditions that predispose patients to resist to lithium prophylaxis, remains an 
underexplored issue. We have highlighted this issue as a gap in research in a recent review (22).  
 
The aim of this study was to investigate the association between response to lithium, clinical 
characteristics of the disorder and childhood trauma in patients with BD.  
 
Material and methods 
 
Sample selection 
The sample consisted of euthymic patients with BD type I, II or not otherwise specified (NOS) who 
were recruited from three academic psychiatric departments in France (Paris/Créteil, Bordeaux and 
Nancy). Patient inclusion criteria for this study were: aged over 18 years; having a diagnosis of BD 
according to DSM-IV criteria (32); being Caucasian; clinically euthymic at the time of inclusion (i.e. 
having a Montgomery Asberg Depression Rating Scale score (33) and a Mania Rating Scale score (34) 
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below five, as well as no major mood episodes in the last three months); having completed the 
Childhood Trauma Questionnaire (35), and whose response to lithium has been assessed using the 
“Alda scale” (2).  
Written informed consent was obtained from all participants. This study was approved by the French 
medical ethics committee (Comité de Protection des Personnes (CPP) - IDRCB2008_AO1465_50 VI—
Pitié Salpêtrière 118-08) and carried out according to the approved guidelines. 
 
Clinical variables related to BD 
Patients were interviewed using the French version (36) of the Diagnostic Interview for Genetic 
Studies (DIGS) (37), which provided lifetime DSM-IV axis I diagnoses (32). A set of variables was 
extracted from the DIGS to characterize the clinical expression of BD. The age at onset (AAO) of BD 
was determined retrospectively and was defined as the age at which a patient first met DSM-IV 
criteria for a major depressive or (hypo)manic episode according to the information collected with 
the DIGS. Polarity at onset of BD was defined as the polarity of the first episode (depressive polarity 
at onset in the case of a first major depressive episode versus manic polarity at onset in case of a 
first (hypo)manic or mixed first episode). Mixed episodes, suicide attempt and rapid cycling were 
recorded as present if they occurred at any point of the course of BD (lifetime presence). Substance 
(alcohol or cannabis) misuse was coded as present if the patient fulfilled the DSM-IV criteria for 
abuse or dependence to these substances at any moment of the course of BD (lifetime presence). 
Misuses with other substances than alcohol or cannabis had a too low prevalence in our sample to 
be studied as such. We also studied the three more frequent comorbid anxiety disorders in our 
sample, i.e. panic disorder, social phobia and generalized anxiety disorder. Other anxiety disorders 
such as obsessive-compulsive disorder had a too low prevalence in our sample to be studied as such. 
 
Assessments 
Childhood traumatic events were assessed using the Childhood Trauma Questionnaire (CTQ), a 28-
item self-report questionnaire (35). The CTQ yields a total score and five subscale scores for 
emotional and physical neglects, as well as emotional, physical and sexual abuses. The CTQ total 
score was used as a continuous variable assessing trauma severity. Based on the cut-off values 
proposed by Bernstein and Fink (38), we used the scores for each subscale to determine the severity 
of each kind of trauma (absent/low, mild, moderate or severe). A trauma subtype was considered as 
present if at least of moderate or severe intensity. This allowed then to define the cumulative 
number of experienced trauma subtypes. In this study, we focussed on abuse types (emotional, 
physical and sexual) rather than types of neglect (emotional and physical). This was because we 
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demonstrated that the associations between childhood trauma and susceptibility to BD or a more 
severe clinical outcome seemed to be mainly driven by abuse rather than neglect (39, 40). 
The “Alda scale” has been designed to retrospectively assess response to lithium (2). This scale 
quantifies the degree of improvement in the course of treatment (A criterion) expressed as a 
weighed against 5 factors (B criteria). The B criteria assessed the number of episodes before/off 
treatment (B1), the frequency of episodes before/off treatment (B2), the duration of the treatment 
(B3), the compliance during period(s) of stability (B4) and the use of additional medication during 
the period of stability (B5). A total score (TS) is then obtained by subtracting the B score from the A 
score. This enables to determine whether the observed improvement is either a result of the 
treatment, a spontaneous improvement or just an effect of additional medication. The “Alda scale” 
was scored for all patients by a trained psychiatrist (CPB). For most analyses, “Alda scale” scores 
were used as continuous variables to maximize the power of the study by avoiding any 
categorization of the scores. When it was relevant to calculate Odd Ratios (OR) and 95% Confidence 
Intervals (95CI), categorized scores were used to allow the comparisons of excellent (scores of 7 to 
10), partial (scores from 2 to 6) and non-responders (scores of 0 or 1) based on the cut-offs validated 
by (4).  
The inclusions of patients were performed between 2005 and 2010 (clinical assessment with the 
DIGS and completion of the CTQ). All Alda scales were then scored in 2012 using the clinical 
information collected between the onset of the disorder (first major mood episode identified using 
the DIGS) and the time at inclusion.  
The response to other mood stabilizing treatments was not determined in this sample. 
 
Statistical analysis 
Scores of the “Alda scale” were compared between groups using non parametric Wilcoxon rank 
tests, since the distribution of the “Alda scale” score did not fit a normal distribution (Kolmogorov-
Smirnov test). Associations between categorical variables were tested using Chi-square tests and if 
appropriate exact tests of Fisher. Odd ratios (OR) were provided when relevant and given with the 
95% Confidence Interval (CI) to quantify the magnitude and direction of any significant associations. 
Correlations between continuous variables were calculated using Spearman correlation tests. 
Multivariable stepwise ordinal logistic regression was used to test for the association between “Alda 
scale” categorized score (0: lithium non responders, 1: partial lithium responders, 2: excellent 
lithium responders) and continuous trauma scores after adjusting for potential confounding 
variables. All analyses were carried out using STATA version 13 software or the IBM SPSS Statistics 
version 21. 
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In that case of a clinical variable being associated to response to lithium, we performed a path 
analysis from childhood trauma score to response to lithium using the clinical variable as a potential 
mediator. The model examined both direct and indirect associations between the trauma score and 
the response to lithium. The model estimated indirect association through the mediator. A path 
diagram representation of the model was then drawn. The path-analysis was performed using 
MPLUS (41).  
 
Results 
 
The sample consisted in 89 females and 59 males with a mean (SD) age at onset of 45.84 (12.25) 
years. Patients mainly suffered from BD type I or II (112 and 34 respectively) with only 2 patients 
suffering from BD NOS. According to “Alda scale” cut-offs, the sample consisted in 20.3% of excellent 
responders, 49.3% of partial responders and 30.4% of non-responders to lithium. 70% of the sample 
had at least two years of lithium treatment and 12% less than one year (“Alda scale” B3 criterion). 
Only 3% of patients were considered as poor adherent to lithium (“Alda scale” B4 criterion).  
Mean (SD) CTQ total score was 41.12 (11.66) (range: 25-78). The frequencies of patients having 
experienced trauma of at least moderate severity were: 22.4% for emotional abuse, 7.5% for 
physical abuse and 17.8% for sexual abuse. Trauma subtypes could be cumulative corresponding to 
52.1% of patients with no trauma, 24.3% with only one trauma subtype and 23.5% with at least two 
trauma subtypes. 
 
First we used “Alda scale” total score and CTQ (sub)scores as continuous variables. We found a 
negative correlation between a higher level of physical abuse and a lower level of response to 
lithium (see table 1). This negative correlation was also observed when restricting the analysis only 
to those patients with at least 2 years of treatment with lithium (rho=-0.21 p=0.03). 
- insert table 1 here - 
 
Regarding the cumulative number of trauma, there was a descending gradient of response to lithium 
from those having no trauma to those having one or two and more trauma subtypes (Linear-by-
Linear Association test p=0.014), suggestive of a dose-effect. Specifically, as compared to patients 
not exposed to any trauma, patients with at least two trauma subtypes were more at risk of 
belonging to the non-responders group (OR=4.91 95CI(1.01-27.02), exact test p=0.03) (see figure 1). 
- insert figure 1 here - 
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As shown in table 2, only one clinical variable was associated with poor response to lithium in our 
sample. those patients with lifetime history of mixed episodes had significantly lower “Alda scale” 
total score meaning that they responded less to lithium. Using categorized scores for the “Alda 
scale” yielded similar results, patients with mixed episodes were more likely to be non-responders 
versus excellent responders as compared to those without mixed episodes (OR=6.76 95CI(1.24-
48.45); exact test p=0.01). We found an association between a lower response to lithium and alcohol 
misuse, also with a trend for an association with rapid cycling. There was no correlation between 
“Alda scale” total score and age at onset (Spearman correlation test rho=0.022 p=0.79), nor with the 
duration of the illness (Spearman correlation test rho=0.029 p=0.73). None of the investigated 
anxiety disorders were associated with response to lithium. 
- insert table 2 here - 
 
We then performed a stepwise ordinal regression using the categorical response status on the “Alda 
scale” as the dependent variable, physical abuse score (continuous) and three following categorical 
clinical variables (lifetime presence versus absence): mixed episodes, rapid cycling and alcohol 
misuse as independent variables. We used 118 observations in the model since some data were 
missing for some variables. A likelihood ratio chi-square of 16.28 was observed (p=0.0003), meaning 
that this model as a whole was statistically significant, as compared to the null model with no 
predictors. Only physical abuse (p=0.005) and presence of mixed episodes (p=0.013) were retained 
in the model and were found to be significantly associated with poor response to lithium (table 3). 
The results of the full model including the 4 independent variables are presented in Supplementary 
table 1. 
- insert table 3 here - 
 
We tested the ability of the model to correctly classify excellent (n=27) versus non responders (n=37) 
(Receiver Operating Characteristics). The Area Under the Curve is 0.75, which is considered to be 
fair. As a whole, 67% of cases were correctly classified (65% of non-responders and 70% of excellent 
responders).   
Finally, the path analysis using physical abuse as the independent variable, “Alda scale” score as the 
dependent variable and lifetime presence of mixed episodes as a potential mediator suggested that 
there was a significant direct effect of physical abuse on “Alda scale” scores (p=0.02) and that the 
indirect effect through mixed episodes was not significant (p=0.74) (see supplementary figure 1). 
 
Discussion 
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In this study we found that poor response to lithium was independently associated with physical 
abuse and lifetime history of mixed episodes. This suggests that physical abuse does not mediate 
poor response to lithium through increased risk of mixed episodes, but rather by a direct effect. 
 
We reported associations between poor response to lithium, mixed episodes and alcohol misuse 
with a trend for an association with rapid cycling. We did not replicate other previously reported 
results such as the association between age at onset and different levels of lithium response. Some 
negative or borderline significant results may be partly explained by the sample size of our study 
that was of reasonable size as compared to previous studies (two thirds of the studies reviewed by 
(6) included less than 100 patients). Only one study has previously reported association between a 
mixed index episode and subsequent response to lithium prophylaxis with borderline p value 
(p=0.06) in a sample of 186 patients with BD (42).  
 
We observed for the first time an association between physical abuse and poor response to lithium. 
This has not been reported by a recently published study (20). This study has a smaller sample size 
than ours (n=135 patients with 92 of them receiving lithium) but similar criteria for euthymia and 
also used the CTQ for assessing childhood trauma. However, some methodological differences 
should be pointed out such as the definition of response to lithium, the prospective design of the 
study and the inclusion of patients with BD type 1 only. Further studies are thus required to confirm 
our observed associations. Further investigations of the association with other subtypes of trauma 
are also required. Indeed the close to zero correlation coefficient (r=-0.02) between sexual abuse 
and “Alda scale” total score might indicate the genuine absence of association in our sample. 
However, the absence of association between emotional abuse and “Alda scale” total score might 
indicate a lack of power in our study (r=-0.13 p=0.12). Research efforts should be then put to 
collecting trauma history when studying response to lithium or merging data within large consortia 
(4). 
 
Given the design of the “Alda scale”, some issues can be raised on whether physical abuse is 
genuinely compromising the response to lithium and/or increases other features related to non-
response. Indeed section A is a measure of improvement with lithium based on the reduction of the 
illness activity whereas part B includes mixed items about compliance during period(s) of stability 
(B4) and the use of additional medication during the period of stability (B5). The total score might 
thus be reduced given an increased B section score. Childhood trauma might lead to more additional 
medication prescriptions or reduced compliance through more complex presentation of the BD (43). 
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However, when looking more closely to sub-scores, physical abuse negatively correlated with part A 
score (rho=-0.24; p=0.003), but not with part B score (rho=0.007; p=0.93). Moreover, partial 
correlation between physical abuse and part A score remained significant when adjusting for part B 
score (rho=-0.20; p=0.016). Clearly, this suggests that the deleterious effect of physical abuse mainly 
acts through a lack of reduction of the illness activity. This is in keeping of the increased number of 
depressive and manic episodes observed among patients with BD who have been exposed to 
childhood trauma (39).  
 
The path-analysis suggested that the effect of physical abuse on response to lithium appeared not to 
be fully mediated by the increased presence of mixed episodes but to have deleterious effects on its 
own. This raises very promising hypothesis to be explored about the molecular mechanisms that 
might drive this effect. We can hypothesize that physical abuse impact on several biological 
pathways (related to inflammatory processes, neuroplasticity, circadian systems or premature 
ageing among others) (22), maybe such effect(s) not being fully counteracted by lithium salts, thus 
explaining why some bipolar patients who received lithium remained at high-risk for mood 
recurrences. For example some studies have shown that childhood trauma reduces BDNF mRNA 
blood levels among exposed schizophrenia spectrum disorders and BD (44, 45) and also modifies 
levels of numerous inflammatory markers in clinical and non-clinical populations (46-48) such as C 
Reactive Protein, Interleukine 6 or Tumor Necrosis Factor alpha (49). This has been proposed to 
create an imbalance between neuroplasticity and pro-inflammatory cytokines levels (50) with some 
increase in BDNF levels being a possible attempt to neutralize the negative effects of childhood 
trauma on the brain. Molecular hypotheses regarding the circadian system are also of great interest 
since the circadian system is targeted by lithium and modulates the biological responses to stressful 
environmental factors (51). Childhood trauma and other stress factors are also causal factors for the 
long-term reduction of telomere length (52, 53). This telomere length shortening is still discussed in 
BD (54) but would be counteracted by lithium (55). Therefore, childhood trauma might be associated 
with poor response to lithium through long-lasting biological consequences.  
 
Childhood trauma also has been associated with long-term effects on prefrontal-limbic brain 
structures. For example, a recent meta-analysis in adults with a history of childhood trauma 
demonstrated that trauma cohorts exhibited smaller hippocampus and amygdala volumes bilaterally 
along with reduced grey matter in the right dorsolateral prefrontal cortex (56). In a sample of 
patients with BD and healthy controls, we found CTQ total scores to be negatively correlated with 
amygdala volumes, prefronto-limbic functional connectivity and uncinate fractional anisotropy (57). 
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Therefore, childhood trauma might alter the volume of and/or connectivity between brain areas that 
might be less sensitive to the potential effects of lithium salts.  
 
Finally, BD is characterized by an altered sensitivity of the HPA axis (increased levels of cortisol (basal 
and post-dexamethasone) and ACTH) as demonstrated by recent meta-analyses and the authors 
have suggested that such an observation seems related to environmental risk factors, such as 
childhood trauma (58, 59). This modification of the sensitivity of the HPA axis might be related both 
to the vulnerability to BD but also to some associated medical conditions such as obesity, diabetes 
type 2 or insulin resistance that in turn would increase the likelihood of non-response to lithium (10-
13). One plausible hypothesis to be further tested is that such medical conditions might influence 
the links between childhood trauma and poor response to lithium, possibly through alterations of 
several inflammatory markers or through the HPA axis. This will represent a new avenue for more 
research about the links between childhood trauma and response to lithium and should be 
investigated in future studies.  
 
This study has several limitations. The sample size remains small (even though reasonable according 
to the available literature), which suggests that some false negative could not definitely be excluded. 
Assessments of clinical presentation of BD and of childhood trauma were done retrospectively which 
might have led to recall bias. The recording of lithium response was also made in a retrospective 
manner based on available information collected with the DIGS. Euthymia was one of the criteria to 
be included in the study; this might have oversampled patients for which stabilization is reachable 
and thus excluding more instable patients with both childhood trauma and poor response to lithium. 
Further studies including also patients with more acute or chronic symptoms might extend our 
findings. The selection of associated clinical variables and correlations with childhood trauma scores 
were performed using the “Alda scale” total score as a continuous variable, while the final regression 
model used three categories based on validated cut-offs (4). This was mainly due to the distribution 
of the “Alda scale” total score in our population, which is very similar to the one observed in 
Manchia et al. (4) (mixture of three Gaussian distributions). The non-normality of this distribution 
and the inability to transform properly the total score to fit a normal distribution prevented us from 
using it as a continuous variable in the regression analysis. Instead we used an ordinal regression 
that might reduce the statistical power to detect some of the associations. A detailed description of 
associated medical conditions was not available in our sample. As such, we were not able to describe 
whether such conditions might also mediate the links between childhood trauma and response to 
lithium in order to go beyond the associations that we reported with mixed episodes. As this was a 
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retrospective study and not a prospective one, we have to emphasize that causality between 
childhood trauma and response to lithium cannot be definitively determined. Finally, we have 
collected no information related to the response to other mood stabilizing agents. Therefore we 
cannot conclude whether the associations found here are specific to lithium or generalizable to 
other mood stabilizers (3).  
 
 
Conclusion 
Childhood trauma might play a role in the non-response to lithium prophylaxis in BD. Physical abuse 
may be particularly involved, although our study suggested that emotional abuse would deserve 
further investigation in larger samples of patients. The association between physical abuse and poor 
response to lithium appeared to be independent of the association observed between poor 
response to lithium and mixed episodes. These results open a new avenue for exploring biological 
mechanisms of poor response to lithium that might be enhanced by the exposure to childhood 
trauma. 
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Table 1: Spearman's correlation coefficients between “Alda scale” total score and CTQ (sub)scores 
  CTQ total score Emotional abuse Physical abuse Sexual abuse 
rho p rho p rho p rho p 
“Alda scale”  total score -0.15 0.07 -0.13 0.12 -0.21 0.009 -0.02 0.85 
CTQ: Childhood Trauma Questionnaire 
Significant correlations are presented in bold. 
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Figure 1: Percentage of excellent, partial and non-responders according to the number of trauma 
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Table 2: Means (SD) for “Alda scale” score according to categorical clinical variables  
Clinical variables Type N Mean SD (yes) Mean SD (no) p 
BD type  I vs II 112 vs 34 3.59 (2.86) 3.85 (2.90) 0.56 
Polarity at onset Depressive vs Manic 83 vs 63 3.42 (2.86) 3.95 (2.85) 0.28 
Rapid cycling Yes vs No 27 vs 110 2.78 (2.88) 3.91 (2.85) 0.071 
Mixed episodes Yes vs No 29 vs 101 2.48 (2.54) 4.09 (2.87) 0.007 
Suicide attempt Yes vs No 60 vs 84 3.90 (3.16) 3.59 (2.70) 0.65 
Alcohol misuse Yes vs No 23 vs 123 2.48 (2.48)  3.88 (2.89) 0.032 
Cannabis misuse Yes vs No 14 vs 132 3.43 (3.00) 3.68 (2.87) 0.77 
Panic disorder Yes vs No 38 vs 106 3.74 (2,68) 3.62 (2.93) 0.87 
Social phobia Yes vs No 20 vs 124 3.10 (2.90) 3.74 (2.85) 0.33 
GAD Yes vs No 10 vs 112 2.60 (3.17) 3.47 (2.82) 0.33 
 
Note: Lower scores of the “Alda scale” indicate lower response to lithium. 
N: number of patients with/without the clinical variable, SD: Standard Deviation, vs = versus. 
Significant differences are presented in bold. 
BD: Bipolar Disorder, GAD: Generalized Anxiety Disorder. 
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Table 3: results of the ordinal stepwise regression analysis  
 
 
 
 
 
 
 
 
 
OR: Odd Ratio, Std. Err.: Standard Error, CI: Confidence Interval 
* Categorical response to lithium as the dependent variable; physical abuse, mixed episodes, rapid 
cycling and alcohol misuse as the dependent variables 
Note: The results were displayed as proportional odds ratios. The odds of excellent response to 
lithium versus the combined partial and non-response was 0.33 lower in the presence of mixed 
episodes, given that all of the other variables in the model are held constant. For each unit increase 
of physical abuse, the odds of excellent response versus the combined partial and non-response was 
0.78 lower, given that all of the other variables in the model are held constant. 
Note: in the ordinal regression, the cut points shown at the bottom of the tables indicated where the 
latent variable was cut to make the three groups that we observed in our data.  Note that this latent 
variable is continuous. 
 
  
Variables* 
OR Std. Err. z P>|z| [95CI] 
Mixed episodes 0.33 0.15 -2.48 0.013 0.14 0.79 
Physical abuse 0.78 0.067 -2.84 0.005 0.66 0.93 
       
/cut1 -2.73 0.59   -3.89 -1.56 
/cut2 -0.33 0.54   -1.39 0.73 
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Supplementary Table 1: results of the ordinal regression analysis (full model)  
 
 
 
 
 
 
 
 
 
 
OR: Odd Ratio, Std. Err.: Standard Error, CI: Confidence Interval 
* Categorical response to lithium as the dependent variable; physical abuse, mixed episodes, rapid 
cycling and alcohol misuse as the dependent variables 
  
Variables* 
OR Std. Err. z P>|z| [95CI] 
Mixed episodes 0.42 0.20 -1.92 0.055 0.17 1.02 
Physical abuse 0.78 0.07 -2.88 0.004  0.66  0.92 
Alcohol misuse  0.60 0.32 -0.95 0.344 0.21 1.71 
Rapid cycling  0.52 0.26 -1.32 0.188 0.20 1.37 
       
/cut1  -2.96 0.62      -4.17 -1.75 
/cut2 -0.50 0.55   -1.58 0.58 
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